Stock NRSN NEUROSENSE THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart NeuroSense Therapeutics Ltd.

Equities

NRSN

IL0011809592

Market Closed - Nasdaq
Other stock markets
 21:30:00 24/05/2024 BST 		5-day change 1st Jan Change
1.167 USD +0.60% Intraday chart for NeuroSense Therapeutics Ltd. -4.34% +48.66%
05-14 NeuroSense Partners with PhaseV for ALS Treatment Trial -- Shares Up MT
05-07 NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
NEUROSENSE THERAPEUTICS LTD.
Bio Therapeutic Drugs
+0.60%-4.34%+48.66%-28.40% - 20.11M
Bearish
Neutral
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. NRSN Stock
  4. Charts NeuroSense Therapeutics Ltd.
  5. Comparison Chart